Fortress Biotech, Inc. - Mar 20, 2024 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
10%+ Owner
Signature
/s/ Samuel Berry, General Counsel and Authorized Agent
Stock symbol
CKPT
Transactions as of
Mar 20, 2024
Transactions value $
$0
Form type
4
Date filed
3/22/2024, 06:23 PM
Previous filing
Jan 3, 2024
Next filing
Apr 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT COMMON STOCK, PAR VALUE $0.0001 Award $0 +194K +10.19% $0.00 2.1M Mar 20, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Fortress Biotech, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The Issuer is required to grant to the Reporting Person an equity fee in shares of the Issuer's Common Stock equal to 2.5% of the gross amount of any debt or equity financing consummated by the Issuer. These shares were granted by the Issuer to the Reporting Person following the closing of a financing.